COMPASS PATHW SP.ADR/ US20451W1018 /
| 2024-09-11 5:42:14 PM | Chg. -0.050 | Volume | Bid5:49:32 PM | Ask5:49:32 PM | High | Low |
|---|---|---|---|---|---|---|
| 6.150EUR | -0.81% | 0 Turnover: 0.000 |
5.900Bid Size: 5,250 | 6.300Ask Size: 4,950 | 6.150 | 6.050 |
GlobeNewswire
08-01
Compass Pathways announces second quarter 2024 financial results and business highlights
GlobeNewswire
05-08
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
05-08
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 st...
GlobeNewswire
05-02
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the deve...
GlobeNewswire
04-29
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the train...
GlobeNewswire
03-28
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia St...
GlobeNewswire
02-29
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights
GlobeNewswire
01-16
Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to dev...
GlobeNewswire
01-05
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
GlobeNewswire
2023-12-19
Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase ...
GlobeNewswire
2023-12-06
Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry
GlobeNewswire
2023-11-15
Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment...
GlobeNewswire
2023-11-02
COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business Highlights
GlobeNewswire
2023-09-06
COMPASS Pathways announces publication of first study evaluating potential of AI model to predict ou...
GlobeNewswire
2023-08-16
COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthca...
GlobeNewswire
2022-03-24
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK
GlobeNewswire
2022-02-24
COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business ...
GlobeNewswire
2022-02-17
COMPASS Pathways plc to announce fourth quarter and full year 2021 financial results on 24 February ...
GlobeNewswire
2022-01-19
Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with...
GlobeNewswire
2022-01-04
COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology
